Technically Speakin...
Health Care: Drugs
Bioheart Inc. (BHRT: OTC)
$0.03 0.00 | 17.19%
06/01/12 - 03:30 PM ET
35.28K / 759.90K
Vol / Avg. Vol:0.03 / 0.03
Open / Prev. Close:0.03 - 0.03
Today's Range:0.02 - 0.26
52 Wk Range:-33.04%
Performance YTD:TheStreet Rating:
Portfolios with BHRT
- Portfolio NameUser Type
- UserRAPTOR SPRTD RED CHIPS-1302...
- UserRAPTOR SPRTD RED CHIPS LIST
- UserRAPTOR SPRTD-0910081159
- UserRAPTOR SPRTD 0510081745
Latest BHRT Headlines from TheStreet
- Bioheart Raises $4 Million To Advance Clinical Trials 01.24.11 | 06:01 am
- Bioheart To Present At Phacilitate's 7th Annual Cell & Gene Therapy Forum 01.14.11 | 06:01 am
- Bioheart Provides Update: Clinical Studies Strategy And Progress 01.10.11 | 04:01 pm
- Bioheart Reports Positive Results For Adipose Derived Stem Cells In Critical Limb Ischemia 01.10.11 | 06:01 am
- Bioheart To Present At LD MICRO Conference 12.03.10 | 09:12 am
Press Releases for BHRT
- Bioheart Set To Present At International Academy Of Cardiology, 16th World Congress On Heart Disease, Annual Scientific Sessions 2011 - PR Newswire 06.16.11 | 05:06 pm
- Bioheart Reports Significant Improvements In Heart Failure Patients From Center Of Excellence Program - PR Newswire 08.26.10 | 03:08 pm
- Bioheart Launches First US FDA Approved Clinical Trial That Tests Gene-Modified Stem Cell Therapy In Patients With Congestive Heart Failure - Business Wire 02.04.10 | 09:02 am
Partner Headlines for BHRT
